NEOGENOMICS INC·4

Dec 15, 8:51 PM ET

Weiss Lawrence Martin 4

4 · NEOGENOMICS INC · Filed Dec 15, 2020

Insider Transaction Report

Form 4
Period: 2020-12-14
Weiss Lawrence Martin
Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2020-12-14$19.60/sh+9,005$176,498120,721 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-12-1416,6668,334 total
    Exercise: $13.87Exp: 2023-12-12Common Stock (16,666 underlying)
  • Exercise/Conversion

    Common Stock

    2020-12-14$6.98/sh+50,000$349,00061,717 total
  • Exercise/Conversion

    Common Stock

    2020-12-14$7.27/sh+20,000$145,40081,717 total
  • Exercise/Conversion

    Common Stock

    2020-12-14$9.22/sh+13,333$122,93095,050 total
  • Exercise/Conversion

    Common Stock

    2020-12-14$13.87/sh+16,666$231,157111,716 total
  • Sale

    Common Stock

    2020-12-14$51.06/sh20,200$1,031,412100,521 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-12-1450,0000 total
    Exercise: $6.98Exp: 2021-03-01Common Stock (50,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-12-149,00527,017 total
    Exercise: $19.60Exp: 2024-03-01Common Stock (9,005 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-12-1420,0000 total
    Exercise: $7.27Exp: 2022-05-25Common Stock (20,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-12-1413,3336,667 total
    Exercise: $9.22Exp: 2023-04-19Common Stock (13,333 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $28.33Exp: 2027-03-02Common Stock (37,514 underlying)
    37,514
Footnotes (6)
  • [F1]On March 1, 2016, Dr. Weiss was granted 50,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
  • [F2]On May 25, 2017, Dr. Weiss was granted 20,000 stock options. These options vested ratably over the first three anniversary dates of the grant date.
  • [F3]On April 19, 2018, Dr. Weiss was granted 20,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F4]On December 12, 2018, Dr. Weiss was granted 25,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
  • [F5]On March 1, 2019, Dr. Weiss was granted 36,022 stock options. These options vest ratably over the first four anniversary dates of the grant date.
  • [F6]On March 2, 2020, Dr. Weiss was granted 37,514 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Documents

2 files
  • 4
    wf-form4_160808347590230.xmlPrimary

    FORM 4

  • EX-24

    WEISS LIMITED POA